Digital Breast Tomosynthesis: What We now Know Beyond the Prevalent Screen.

Catherine M Tuite1, Sara C Gavenonis1

  • 1Division of Breast Imaging, ChristianaCare, Department of Radiology, Helen F Graham Cancer Center and Research Institute, Newark, DE, USA.

Summary

Digital breast tomosynthesis (DBT) shows promise in cancer screening, but further research beyond initial screenings is needed. Evaluating subsequent screening rounds is crucial to understand its long-term impact on detecting cancers and reducing advanced disease.

Related Concept Videos